The largest global commercially-focused event for next-generation medicine and genomics, The World Precision Medicine Congress USA, has released its updated brochure. The new event description includes more than 50 new speakers and roundtable participants, including the vital perspectives of Venture Capital and Payers.
The new brochure can be downloaded here: http://goo.gl/6mhiku
With its continually growing tally of speakers up to over 100, this brochure release solidifies the event's seminal role as the largest commercial event to date in driving towards the vision President Obama outlined in last year's announcement of the Precision Medicine Initiative (PMI).
A few of the new event participants include Chairperson Mark Clein, Co-Founder and President of the Precision for Medicine Group and successful biotech entrepreneur, as well as Ed Pezalla, who deals with Pharmaceutical Strategy at Aetna, one of the largest health insurance companies in the United States. They are joining an already expansive list, including FDA Commissioner Robert Califf and C-level executives from Pharma and Health Systems.
For more information, download the brochure: http://goo.gl/6mhiku
"In adding more people to the agenda, the most important thing we looked for was commerciality," says Event Director Chris Hackett. "There are lots of great events out there that focus on the distant, conceptual future, and those are important. The industry now wants one that focuses on the granular, actionable issues on both the scientific and commercial ends of the spectrum."
The commercial focus was driven by several additions. The first was a venture capital roundtable, which emphasizes investing on disease-specific metrics as opposed to company specific. The other was the addition of a payer-focused panel, discussing reimbursement for next-generation diagnostics and new payment structures for precision medicine.
The World Precision Medicine Congress USA 2016 is taking place November 14-15th at the Hyatt Regency Capitol Hill in Washington, D.C.